RBP4 interferes with tongue squamous cell carcinoma progression by inhibiting the PI3K/AKT signaling pathway and
Ying Yan1, Nan Miao1, Xiaofeng Wang2
1Department of Stomatology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Abstract:
Tongue squamous cell carcinoma (TSCC) is a common type of oral mucosal epithelial malignancy that can severely affect patient quality of life. Therefore, novel therapeutic strategies for TSCC are needed. This study aimed to investigate the role and mechanism of action of retinol-binding protein 4 (RBP4) in TSCC progression and its effect on tumor-associated macrophages. To this end, TSCC cell lines with RBP4 overexpression and knockdown were constructed, and effects of RBP4 expression on the proliferation and invasive abilities of TSCC cells were verified using ex vivo experiments. Furthermore, a tumor cell-macrophage co-culture model was established to assess the effect of RBP4 on macrophage polarization. RBP4 overexpression reduced the phosphorylation of the PI3K/Akt/mTOR pathway and inhibited tumor cell proliferation by regulating Snail levels; RBP4 inhibited TSCC cells from undergoing epithelial-mesenchymal transition. In addition, RBP4 promoted the activation of NF-κB signaling pathway, leading to macrophage polarization toward M1 type and inhibiting TSCC growth. We found for the first time that RBP4 affects the proliferation and migration of TSCC cells by inhibiting the activation of the PI3K-Akt signaling pathway, and that RBP4 promotes the M1-type polarization of tumor-associated macrophages, which contributes to their antitumor effects.
Insights
Retinol-binding protein 4 (RBP4) inhibits tongue squamous cell carcinoma (TSCC) growth by reducing tumor cell proliferation and promoting anti-tumor M1 macrophage polarization. This study reveals RBP4 as a potential therapeutic target for TSCC.
Area of Science:
- Oncology
- Immunology
- Molecular Biology
Background:
- Tongue squamous cell carcinoma (TSCC) significantly impacts patient quality of life, necessitating novel therapeutic strategies.
- Understanding the molecular mechanisms driving TSCC progression and immune evasion is crucial for developing effective treatments.
Purpose of the Study:
- To investigate the role and mechanism of retinol-binding protein 4 (RBP4) in TSCC progression.
- To determine RBP4's effect on tumor-associated macrophage (TAM) polarization and its impact on TSCC growth.
Main Methods:
- TSCC cell lines with altered RBP4 expression (overexpression and knockdown) were created.
- Ex vivo experiments assessed RBP4's impact on TSCC cell proliferation and invasion.
- A co-culture model examined RBP4's influence on macrophage polarization via NF-κB and PI3K/Akt/mTOR signaling pathways.
Main Results:
- RBP4 overexpression inhibited TSCC cell proliferation and epithelial-mesenchymal transition by reducing PI3K/Akt/mTOR pathway phosphorylation and regulating Snail levels.
- RBP4 promoted M1-type polarization of tumor-associated macrophages through NF-κB pathway activation.
- RBP4 demonstrated antitumor effects by inhibiting TSCC growth and migration.
Conclusions:
- RBP4 inhibits TSCC cell proliferation and migration by suppressing the PI3K-Akt signaling pathway.
- RBP4 promotes M1-type polarization of TAMs, contributing to their antitumor activity.
- RBP4 represents a promising therapeutic target for tongue squamous cell carcinoma.
More Related Videos
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
11:13Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
Published on: June 9, 2023
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation
The Ras Gene
Ras is a...
The JAK-STAT Signaling Pathway
Negative Regulator Molecules
